Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Ixekizumab helps improve life quality, physical ability, and work performance in patients with psoriatic arthritis who haven't used biologic drugs before.

Using regulatory T cells and Rapamycin together improves chronic graft-versus-host disease treatment outcomes in mice.

Macrophages play a crucial role in skin wound healing, with their numbers and sizes changing over time.

Icariin can regulate macrophages and may help treat inflammation, cancer, bone disorders, and fibrotic diseases.

Enhancing regulatory T cells may help treat autoimmune diseases like alopecia areata.

Immune therapy for cancer can cause hair loss scars in some patients.

Age-related immune changes significantly affect disease development in other systems.

Researchers found that certain miRNAs, which affect immune system regulation, are differently expressed in mice with a hair loss condition compared to healthy mice.

Choosing the right tools is crucial for accurately measuring lupus activity and damage.

Patients with severe alopecia areata have higher levels of MIF, which decrease after successful treatment.

The IPP index is linked to storage symptoms and leftover urine, and may help manage urinary tract symptoms.

Patients with alopecia areata have higher levels of certain immune markers, suggesting new treatment targets.

IL-3 worsens lupus nephritis and blocking it improves kidney health.

Iron deficiency worsens inflammatory skin diseases by disrupting iron balance and increasing inflammation.

Long-term Imiquimod treatment causes initial skin inflammation that lessens over time, and topical corticosteroids reduce this inflammation and cytokines in a mouse model of psoriasis.

IL-9/IL-9R signaling can negatively affect human hair growth and may be a target for treating hair loss conditions.

The ID2 gene can help distinguish between sensitizers and irritants in skin cells.

Two men experienced hair regrowth while being treated with immune globulin for other health issues, but there were also side effects.

An automated system can predict death risk in thin melanoma by analyzing immune cells.

Removing certain immune cells in mice causes their hair to enter the growth phase earlier than usual.

iNKT cells help develop and maintain healthy skin in young mice.

Higher BMI may increase the risk of psoriasis and some other skin diseases.

Interleukin levels are higher in alopecia areata patients but don't predict disease severity or duration.

TLR3 signaling enhances the immunosuppressive properties of human periodontal ligament stem cells.

Blocking interferon-gamma might help treat various autoimmune diseases.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

IL-1 receptor absence in mice leads to skin cysts and changes in immune response after UVB exposure.

Alopecia areata patients have fewer protective regulatory B cells, which may contribute to the disease.